Contract award · HT942726CE013
RESEARCH AND DEVELOPMENT DHA PHASE II SBIR FOR PROJECT TITLED, FIELD-DEPLOYABLE NEUROPROTECTIVE LIPOSOMES FOR THE TARGETED TREATMENT OF TRAUMATIC BRAIN INJURY
Awarded to LUNA LABS USA LLC · CAGE 8JML8
Latest reported total obligated
Not reported
Net observed obligations
$1.3M
Observed contract actions
2
Observed period
FY2026–FY2026
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorLUNA LABS USA LLC
CAGE8JML8
CustomerDefense Health Agency
Performance locationCHARLOTTESVILLE, VIRGINIA, UNITED STATES
Procurement details
First observed actionApr 7, 2026
Latest observed actionJun 12, 2026
PSCAN12
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
SolicitationHQ003420RBDST
Annual observed obligations
FY2026
$1.3M
Continue exploring
Ask Mimir about HT942726CE013
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.